fbpx

Morning News Round-up:

Ø  WB cuts global economic outlook despite oil price drop

Ø  India’s trade deficit with China rose to $37.8 bn

Ø  Timing of CIL stake sale to be decided by FinMin: Coal Secy

Ø  Tata Motors global sales up 8 per cent in December

Ø  Oil prices down again as UAE defends production hold

Ø  Court bars Cipla from selling copy of Novartis respiratory drug
 
Ø  Crude price slump a boon for India, says RBI

Ø  Govt rethinks CIL, ONGC stake sale as stocks fall

Ø  Lakshmi Vilas Bank profit up by 338.68 % in Dec quarter

Ø  IndusInd Bank Q3 profit up over 29% meets street estimate

Ø  RBI against broad-basing CRR to include forex, gold

Ø  Clariant Chemicals hits record high on interim dividend of Rs 140 per share

Ø  MFs directed to stop dividend re-investments in ELSS

Ø  Crude oil plunges again as UAE defends holding production

Ø  Wipro Enterprises gets nod for share capital reduction

Ø  SsangYong turnaround still not complete, says Mahindra

Ø  India’s oilseed production should be linked to food security, says industry

Ø   SEBI clears charges against India Infoline Finance

Ø  Cotton output estimates stand at 407 lakh bales       
 
Ø  Tata’s offer for DoCoMo buy-back gets RBI nod

Ø  Govt proposes ban on sale of loose cigarettes

Ø  Domestic drug sales cross Rs87,000 crore despite pricing control

Ø  Govt issues executive order to start mineral mine auctions

Ø  Sebi seeks fresh clarification on Videocon d2h’s Rs700 cr IPO

Ø  Debt markets start pricing in February rate cut after CPI data

Ø  DCB Bank Q3 profit up 17% at Rs42.5 crore

Ø  High Court restrains TCS from retrenching its analyst

Ø  Indian rupee ends near one-month highs vs US dollar, up 2 paise at 62.14

Ø  BSE Sensex falls 159.54 pts to end at 27,425.73; Nifty closes at 8,299.40

Ø  Rel Ind, BP, Cairn India suggest gas price at $5.7-7.4 per unit

Ø   Investors may cut India slack on deficit target, if Union budget credible
 
Ø  Sebi eases norms for offshore funds biz

Ø  RCom loses 2% market share in one year

Ø  Vivimed targets 25% growth to achieve Rs 5,000 cr sales

Ø  Remittance regulations for persons under Fema

Ø  Fresh investors enter at fastest pace: NSDL

Ø  China Dec exports beat expectations, but pressures persist

Looking for Best Stock Broker in India?

we will help you to find best broker with Free demat & lowest brokerage